Wells Fargo’s Ocugen OCGN Stock Holding History

Wells Fargo’s Portfolio OCGN Stock Details OCGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-4,500	Closed	-$46K	–	7350
2021 Q2	$46K	Buy	+4,500	New	+$38K	﹤0.01%	5590

Other funds holding OCGN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return

GMT Capital Atlanta, Georgia $1.92B AUM 70.51% 1-Year Est. Return

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Wells Fargo's OCGN Position: Q2 2026 in Review

Wells Fargo increased its Ocugen (OCGN) stake by 312% in Q2 2026, buying an estimated $369K and bringing the position to 320,617 shares worth $491K. The position accounts for ﹤0.01% of the portfolio, ranked #4643.

Wells Fargo first reported a position in OCGN in Q1 2017 and has held it in 29 quarters since. The position peaked at $1.15M in Q3 2021. 147 funds tracked by Wall St. Rank hold OCGN as of Q2 2026.

Wells Fargo held 320,617 shares of Ocugen worth $491K as of Q2 2026.
Wells Fargo bought 242,716 Ocugen shares in Q2 2026, an estimated $369K.
Ocugen made up ﹤0.01% of Wells Fargo's portfolio in Q2 2026, its #4643 holding.
Wells Fargo first reported a position in Ocugen in Q1 2017 and has held it in 29 quarters since.
Wells Fargo's Ocugen position peaked at $1.15M in Q3 2021.
147 funds tracked by Wall St. Rank held Ocugen as of Q2 2026.

Based on Wells Fargo's 13F filing for Q2 2026, filed 14 Aug 2026.